0001127602-22-003426.txt : 20220204 0001127602-22-003426.hdr.sgml : 20220204 20220204172107 ACCESSION NUMBER: 0001127602-22-003426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ridha Essra CENTRAL INDEX KEY: 0001888732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38537 FILM NUMBER: 22594622 MAIL ADDRESS: STREET 1: C/O AVROBIO, INC. STREET 2: ONE KENDALL SQUARE, BLDG 300 - SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc. CENTRAL INDEX KEY: 0001681087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810710585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7819626030 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AvroBio, Inc. DATE OF NAME CHANGE: 20160729 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-02 0001681087 AVROBIO, Inc. AVRO 0001888732 Ridha Essra C/O AVROBIO, INC. ONE KENDALL SQUARE, BLD. 300 - SUITE 201 CAMBRIDGE MA 02139 1 Chief Medical Officer Stock Option (Right to Buy) 1.84 2022-02-02 4 A 0 75000 0 A 2032-02-01 Common Stock 75000 75000 D Stock Option (Right to Buy) 1.84 2022-02-02 4 A 0 80000 0 A 2032-02-01 Common Stock 80000 80000 D 25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. /s/ Christopher Gerry, Attorney in Fact for Essra Ridha 2022-02-04